论文部分内容阅读
1998年12月25日，由湖北省肿瘤医院和中国科学院武汉病毒研究所合作完成的EBV感染、p53、Bcl－2、C－myC基因表达与肺癌关系研究课题通过了由湖北省卫生厅组织的专家鉴定。湖北省肿瘤医院病理科夏和顺副主任医师等人花了近两年的时间，采用现代分子生物学的方法对多种类型肺癌
On December 25, 1998, the research project on the relationship between EBV infection, p53, Bcl-2, C-myC gene expression and lung cancer completed by the Hubei Provincial Cancer Hospital and Wuhan Institute of Virology, Chinese Academy of Sciences, was organized by the Hubei Provincial Department of Health. Expert identification. Xia Heshun, deputy chief physician of Pathology Department of Hubei Cancer Hospital, and others spent nearly two years, using modern molecular biology methods for many types of lung cancer.